NeuroBo Pharmaceuticals, Inc. (NRBO) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

NRBO Income statement / Annual

Last year (2025), 's total revenue was $0.00, and the percentage change from the previous year is not available. In 2025, 's net income was -$12.97 M. See ,s key income statements, including revenue, expenses, profit, and income.

Period FY-2025 FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2025 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $7.00 K $28.00 K $72.00 K $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 -$7.00 K -$28.00 K -$72.00 K -$67.00 K -$17.00 K $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $6.80 M $21.55 M $9.15 M $2.75 M $6.55 M $21.87 M $5.32 M $14.31 M $22.69 M $8.74 M
General & Administrative Expenses $6.91 M $7.26 M $6.73 M $8.64 M $8.75 M $7.85 M $2.70 M $8.49 M $10.44 M $5.96 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $6.91 M $7.26 M $6.73 M $8.64 M $8.75 M $7.85 M $2.70 M $8.49 M $10.44 M $5.96 M
Other Expenses $0.00 $0.00 $0.00 -$83.00 K $0.00 -$1.00 K $12.15 M $0.00 $0.00 $0.00
Operating Expenses $13.71 M $28.81 M $15.88 M $11.42 M $15.30 M $29.72 M $20.18 M $22.81 M $33.12 M $14.70 M
Cost And Expenses $0.00 $0.00 $15.89 M $11.42 M $15.30 M $29.72 M $20.18 M $22.81 M $33.12 M $14.70 M
Interest Income $0.00 $920.00 K $461.00 K $2.19 K $14.00 K $39.00 K $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $2.19 M $0.00 $39.00 K $22.00 K $654.00 K $0.00 $0.00
Depreciation & Amortization $0.00 $0.00 $7.00 K $28.00 K $48.00 K $46.00 K $17.00 K $6.67 M $60.00 K -$17.00 K
EBITDA -$13.71 M -$28.81 M -$12.46 M -$11.39 M -$15.24 M -$29.61 M -$21.17 M -$15.49 M -$33.09 M -$14.50 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $735.00 K $1.22 M $3.42 M $5.66 M $14.00 K $38.00 K -$1.14 M -$832.00 K -$291.00 K $110.00 K
Income Before Tax -$12.97 M -$27.59 M -$12.47 M -$13.97 M -$15.28 M -$29.68 M -$21.31 M -$15.53 M -$33.42 M -$14.59 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $654.00 K $286.00 K -$137.00 K
Net Income -$12.97 M -$27.59 M -$12.47 M -$13.97 M -$15.28 M -$29.68 M -$21.31 M -$23.64 M -$33.42 M -$14.59 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -7.35 -3.56 -2.46 -19.01 -157.85 -439.2 -1030.5 -166.8 -2421.73 -1883.28
EPS Diluted -7.35 -3.56 -2.46 -19.01 -157.85 -439.2 -1030.5 -166.8 -2421.73 -1883.28
Weighted Average Shares Out $1.77 B $77.57 M $5.07 M $321.70 K $96.43 K $67.57 K $21.00 K $17.71 K $13.80 K $7.75 K
Weighted Average Shares Out Diluted $1.77 B $77.57 M $5.07 M $321.70 K $96.43 K $67.57 K $21.77 K $17.71 K $13.80 K $7.75 K
Link